Ignite Creation Date:
2024-05-06 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04714086
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2023-09-25
First Post:
2021-01-14
Brief Title:
Expanded Access Program for Avapritinib
Sponsor:
Blueprint Medicines Corporation
Organization:
Blueprint Medicines Corporation
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2021-01-14
First Submit QC Date:
January 14 2021
Study First Post Date:
2021-01-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-22
Last Update Post Date:
2023-09-25
Last Update Post Date Type:
ACTUAL